Matches in Wikidata for { <http://www.wikidata.org/entity/Q64348950> ?p ?o ?g. }
Showing items 1 to 38 of
38
with 100 items per page.
- Q64348950 description "clinical trial" @default.
- Q64348950 description "ensayu clínicu" @default.
- Q64348950 description "klinisch onderzoek" @default.
- Q64348950 description "клінічне випробування" @default.
- Q64348950 name "A Study of Palbociclib in Combination With Adjuvant Endocrine Therapy for Hormone Receptor Positive, HER2 Negative Invasive Breast Cancer" @default.
- Q64348950 type Item @default.
- Q64348950 label "A Study of Palbociclib in Combination With Adjuvant Endocrine Therapy for Hormone Receptor Positive, HER2 Negative Invasive Breast Cancer" @default.
- Q64348950 prefLabel "A Study of Palbociclib in Combination With Adjuvant Endocrine Therapy for Hormone Receptor Positive, HER2 Negative Invasive Breast Cancer" @default.
- Q64348950 P1132 Q64348950-A7F98474-A75B-4187-88DD-9DD97482FA5A @default.
- Q64348950 P1476 Q64348950-42D90D78-E167-4D0A-8B16-9B0EB79A4DBF @default.
- Q64348950 P17 Q64348950-4A61CECF-E948-4810-B67C-8E7B338DD93D @default.
- Q64348950 P2899 Q64348950-586060B6-B9CD-46C3-94C8-274B378E109A @default.
- Q64348950 P3098 Q64348950-076D172E-7424-4758-A72A-5BF4140FE394 @default.
- Q64348950 P31 Q64348950-43DF89F6-C5BC-407C-B452-E171A34F4E2B @default.
- Q64348950 P4844 Q64348950-4CD77A59-BBE9-4897-ACB8-4B0AC47B9D87 @default.
- Q64348950 P580 Q64348950-1663A95D-895D-4FFF-AE2A-99B641A69765 @default.
- Q64348950 P582 Q64348950-1FE06094-463D-4B14-B328-B4E5DB59F375 @default.
- Q64348950 P6099 Q64348950-F51FAD98-B93F-46F6-A113-A8E4D8509EE9 @default.
- Q64348950 P6153 Q64348950-5CAE99BC-0537-4DE0-A31D-0ED28FFA342F @default.
- Q64348950 P6153 Q64348950-92A4B4E1-FBDA-4D75-BB1F-0E0BB8EEDA06 @default.
- Q64348950 P6153 Q64348950-B60299A7-7E6D-4A92-A1DB-4D6BB6715476 @default.
- Q64348950 P6153 Q64348950-C3E75B8C-4286-4ADE-9F06-564960060B37 @default.
- Q64348950 P8363 Q64348950-776EA3CA-1747-4DC7-9B0A-0BD001460ECE @default.
- Q64348950 P1132 "+160" @default.
- Q64348950 P1476 "A Phase 2 Pilot Feasibility Study of Palbociclib in Combination With Adjuvant Endocrine Therapy for Hormone Receptor Positive Invasive Breast Carcinoma" @default.
- Q64348950 P17 Q30 @default.
- Q64348950 P2899 "+18" @default.
- Q64348950 P3098 "NCT02040857" @default.
- Q64348950 P31 Q30612 @default.
- Q64348950 P4844 Q412178 @default.
- Q64348950 P580 "2014-01-01T00:00:00Z" @default.
- Q64348950 P582 "2018-05-01T00:00:00Z" @default.
- Q64348950 P6099 Q42824440 @default.
- Q64348950 P6153 Q1061104 @default.
- Q64348950 P6153 Q1159198 @default.
- Q64348950 P6153 Q126412 @default.
- Q64348950 P6153 Q4897536 @default.
- Q64348950 P8363 Q78089383 @default.